Vanderheyden M, Goethals M, Nellens P, Andries E, Brugada P
Cardiovascular Center, O.L.V. Ziekenhuis, Aalst, Belgium.
Am Heart J. 1998 Jan;135(1):67-73. doi: 10.1016/s0002-8703(98)70344-8.
Neurocardiogenic dysfunction is believed to result from activation of ventricular mechanoreceptors. To asses other humoral and circulatory mechanisms activated during vasovagal syncope, epinephrine, norepinephrine, renin, and aldosterone levels were measured during head-up tilt testing. Twenty-three patients referred because of vasovagal syncope underwent passive head-up tilt testing (80 degrees). Blood samples were taken at baseline, after 30 minutes of supine rest and at syncope. Five patients (four men, one woman; mean age 46 +/- 27 years) had cardioinhibitory syncope. Seven patients (five men, two women; mean age 40 +/- 12 years) had vasodepressor syncope. Eleven patients (eight men, three women; mean age 55 +/- 21 years) had negative results of head-up tilt tests. Among patients with cardioinhibitory syncope, norepinephrine concentration rose significantly from baseline to syncope (0.44 +/- 0.12 ng/ml versus 1.14 +/- 0.72 ng/ml; p < 0.05), whereas no significant change was observed in epinephrine (0.08 +/- 0.03 ng/ml versus 2.74 +/- 2.85 ng/ml; p = not significant [NS]), renin (5.68 +/- 3.03 pg/ml versus 19.58 +/- 11.47 pg/ml; p = NS), or aldosterone concentration (66.60 +/- 16.10 ng/ml versus 109.00 +/- 44.70 ng/ml; p = NS). Patients with vasodepressor syncope had a significant rise in renin (9.03 +/- 4.56 pg/ml versus 52.53 +/- 41.63 pg/ml; p < 0.05) and aldosterone concentration (95.43 +/- 103.03 ng/ml versus 249.57 +/- 191.54 ng/ml; p < 0.05), whereas no change in level of epinephrine (0.12 +/- 0.12 ng/ml versus 0.28 +/- 0.33 ng/ml; p = NS) or norepinephrine (0.60 +/- 0.26 ng/ml versus 0.86 +/- 0.53 ng/ml; p = NS) was detected. Among patients with negative results of tilt tests, levels of renin (7.94 +/- 7.19 pg/ml versus 27.71 +/- 18.50 pg/ml; p < 0.01) and aldosterone (64.64 +/- 28.33 ng/ml versus 160.91 +/- 79.58 ng/ml; p < 0.01) rose significantly, whereas no change was seen in epinephrine (0.12 +/- 0.14 ng/ml versus 0.23 +/- 0.31; p = NS) or norepinephrine concentration (0.54 +/- 0.21 ng/ml versus 0.82 +/- 0.52; p = NS). Patients with cardioinhibitory syncope were characterized by a rise in norepinephrine level and blunted activation of the renin-angiotensin-aldosterone axis at syncope. Unlike patients with cardioinhibitory syncope, the renin-angiotensin-aldosterone axis is activated in patients with vasodepressor syncope and patients with a negative result of head-up tilt test without a statistically significant increase in catecholamine levels. Patients with cardioinhibitory syncope have higher epinephrine levels at syncope compared with patients with a negative result of head-up tilt test and patients with vasodepressor syncope.
神经心源性功能障碍被认为是由心室机械感受器激活所致。为评估血管迷走性晕厥期间激活的其他体液和循环机制,在头高位倾斜试验期间测量了肾上腺素、去甲肾上腺素、肾素和醛固酮水平。23例因血管迷走性晕厥就诊的患者接受了被动头高位倾斜试验(80度)。在基线、仰卧休息30分钟后及晕厥时采集血样。5例患者(4例男性,1例女性;平均年龄46±27岁)发生心脏抑制性晕厥。7例患者(5例男性,2例女性;平均年龄40±12岁)发生血管减压性晕厥。11例患者(8例男性,3例女性;平均年龄55±21岁)头高位倾斜试验结果为阴性。在心脏抑制性晕厥患者中,去甲肾上腺素浓度从基线到晕厥时显著升高(0.44±0.12 ng/ml对1.14±0.72 ng/ml;p<0.05),而肾上腺素(0.08±0.03 ng/ml对2.74±2.85 ng/ml;p=无显著性差异[NS])、肾素(5.68±3.03 pg/ml对19.58±11.47 pg/ml;p=NS)或醛固酮浓度(66.60±16.10 ng/ml对109.00±44.70 ng/ml;p=NS)无显著变化。血管减压性晕厥患者肾素(9.03±4.56 pg/ml对52.53±41.63 pg/ml;p<0.05)和醛固酮浓度(95.43±103.03 ng/ml对249.57±191.54 ng/ml;p<0.05)显著升高,而肾上腺素水平(0.12±0.12 ng/ml对0.28±0.33 ng/ml;p=NS)或去甲肾上腺素(0.60±0.26 ng/ml对0.86±0.53 ng/ml;p=NS)无变化。在倾斜试验结果为阴性的患者中,肾素(7.94±7.19 pg/ml对27.71±18.50 pg/ml;p<0.01)和醛固酮(64.64±28.33 ng/ml对160.91±79.58 ng/ml;p<0.01)水平显著升高,而肾上腺素(0.12±0.14 ng/ml对0.23±0.31;p=NS)或去甲肾上腺素浓度(0.54±0.21 ng/ml对0.82±0.52;p=NS)无变化。心脏抑制性晕厥患者的特点是去甲肾上腺素水平升高,且晕厥时肾素-血管紧张素-醛固酮轴激活减弱。与心脏抑制性晕厥患者不同,血管减压性晕厥患者和头高位倾斜试验结果为阴性的患者肾素-血管紧张素-醛固酮轴被激活,而儿茶酚胺水平无统计学意义的显著升高。与头高位倾斜试验结果为阴性的患者和血管减压性晕厥患者相比,心脏抑制性晕厥患者晕厥时肾上腺素水平更高。